HAGLR and neoplasm: HAGLR (also known as HOXD-AS1), a long non-coding RNA, has been implicated in transcriptional regulation linked to tumor progression, epithelial–mesenchymal transition, and immune suppression, suggesting a role in shaping immunosuppressive tumor states that may limit immunotherapy efficacy [38,39].